Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Clinical trial NCT00095199 · COMPLETED
Trial details
- NCT number
- NCT00095199
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2011-07-01
- Enrollment
- 939
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.